[Values of Detecting the Levels of ß2-MG, TNF-α, CRP, IL-6 in the Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 23(5): 1362-5, 2015 Oct.
Article
en Zh
| MEDLINE
| ID: mdl-26524038
ABSTRACT
OBJECTIVE:
To explore the values of detecting the serum levels of ß2-MG, TNF-α, CRP, IL-6 in the patients with multiple myeloma.METHODS:
A total of 40 patents with multiple myeloma were included in the experiment group, and 40 healthy volunteers were selected as the control group. The levels of ß2-MG, TNF-α, CRP and IL-6 were detected and compared in 2 groups, the different durie-salmon (DS) stages of ß2-MG, TNF-α, CRP and IL-6 in the experiment group were analyzed.RESULTS:
The levels of ß2-MG, CRP, IL-6 in the experiment group were higher than those in control group (P < 0.05); the level of TNF-α in the experiment group was lower than that in control group (P < 0.05); the levels of ß2-MG, CRP, IL-6 at stage I, II, III in the experiment group was higher than those in control group (P < 0.05); the level of TNF-α at stage I, II, III in the experiment group was lower than that in the control group (P < 0.05); the levels of ß2-MG, CRP, IL-6 at stage I, II, III in the experiment group displayed an increasing tendency, the levels of TNF-α at stage I, II, III in the experiment group displayed a declining trend (P < 0.05); the levels of ß2-MG, CRP, IL-6 in the experiment group after treatment for 8, 16 weeks were higher than those in control group (P < 0.05); the level of TNF-α in the experiment group after treatment for 8, 16 weeks was lower than that in control group (P < 0.05); the levels of ß2-MG, CRP and IL-6 in the experiment group after treatment for 16 weeks were lower than those for 8 weeks (P < 0.05); the levels of TNF-α in the experiment group after treatment for 16 weeks were higher than those for 8 weeks (P < 0.05). The levels of APE1 after treatment in the experiment group were lower than that before treatment.CONCLUSION:
The serum levels of ß2-MG, TNF-α, CRP and IL-6 can be as index for diagnosis of multiple myeloma, can effectively evaluate the disease severity; their combination with APE1 expression level can evaluate the therapeutic efficacy; thus the detection of above-mentioned indexes is possessed of higher value for clinical applications.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Proteína C-Reactiva
/
Microglobulina beta-2
/
Interleucina-6
/
Factor de Necrosis Tumoral alfa
/
Mieloma Múltiple
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
Idioma:
Zh
Revista:
Zhongguo Shi Yan Xue Ye Xue Za Zhi
Asunto de la revista:
HEMATOLOGIA
Año:
2015
Tipo del documento:
Article